TTNP - Titan Pharmaceutical...About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $0.14 | Open | $0.14 |
| Volume | 5.61M | Market Cap | 16.64M |
| Yield | Last Dividend |
| The Daily Biotech Pulse: Amarin Vascepa ... | 10/16/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 15) Ami... | |
| Titan Pharmaceuticals Provides a Strateg... | 10/15/20 |
| SOUTH SAN FRANCISCO, Calif., Oct. 15, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) ("Titan" or the "Company") today announced a stra... | |
| Titan's Probuphine?? Commercialization P... | 09/15/20 |
| SOUTH SAN FRANCISCO, Calif., Sept. 15, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that... | |
| Titan Pharmaceuticals Provides Update To... | 09/14/20 |
| SOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today provided an up... | |
| Titan Pharmaceuticals Reports Second Qua... | 08/14/20 |
| SOUTH SAN FRANCISCO, Calif., Aug. 14, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) ("Titan" or the "Company") today ??? | |
| Thinking about buying stock in SINTX Tec... | 06/24/20 |
| NEW YORK, June 24, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SINT, KTOV, TTNP, TMUS, and NIO. To see how InvestorsO... | |
| Titan Pharmaceuticals And Indegene Enter... | 06/24/20 |
| SAN FRANCISCO, June 24, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has entered... | |
| Titan Pharmaceuticals Launches Virtual R... | 06/16/20 |
| /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has initiated a fully-virtual Probuphine... | |
| Titan Pharmaceuticals, Inc. (TTNP): Q4 2... | 03/30/20 |
| ??? Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) reported a loss of $0.08 per share in the fourth quarter of 2019, in line with Wall Street expectation.... | |
| Titan Pharmaceuticals Announces Pricing ... | 01/07/20 |
| SOUTH SAN FRANCISCO, Calif. , Jan. 7, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) today announced it has entered into a securitie... | |
| Titan Pharmaceuticals Appoints Dr. Kate ... | 12/30/19 |
| SOUTH SAN FRANCISCO, Calif., Dec. 30, 2019 /PRNewswire/ -- Titan Pharmaceuticals, Inc. today announced that at its recent annual stockholders meeting,... | |
| Titan Pharmaceuticals Reports Third Quar... | 11/14/19 |
| SOUTH SAN FRANCISCO, Calif., Nov. 14, 2019 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today reported financial results for the third q... | |
| The Daily Biotech Pulse: Intuitive Surgi... | 10/18/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 17) ... | |
| The Daily Biotech Pulse: Arbutus Halts H... | 10/04/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 3) Ap... | |
| The Daily Biotech Pulse: Enanta Aces Mid... | 09/26/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs S... | |
| The Daily Biotech Pulse: All Eyes On Aim... | 09/13/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 11)... | |
| The Daily Biotech Pulse: Glaukos To Buy ... | 08/08/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 7) A... | |
| Titan Pharmaceuticals, Inc. (TTNP) CEO S... | 05/15/19 |
| Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Q1 2019 Results Earnings Conference Call May 15, 2019, 04:30 PM ET Company Participants Sunil Bhonsle - Pres... | |
| Titan Pharmaceuticals misses by $0.08, m... | 05/15/19 |
| No summary available. | |
| Health Care Sector Update for 04/29/2019... | 04/29/19 |
| Top Health Care StocksTop Health Care Stocks JNJ 0 14 JNJ 0 14 PFE 0 18 PFE 0 18 ABT 0 44 ABT 0 44 MRK 0 35 MRK 0 35 AMGN 0 18 AMGN 0 18 Health care s... | |
| Health Care Sector Update for 04/29/2019... | 04/29/19 |
| Top Health Care Stocks Top Health Care Stocks JNJ 0 12 JNJ 0 12 PFE 0 18 PFE 0 18 ABT 0 03 ABT 0 03 MRK 0 23 MRK 0 23 AMGN FlatAMGN Flat Monday pre ma... | |
| European advisory group backs Titan Phar... | 04/29/19 |
| No summary available. | |
| Titan Pharma inks $8.6M stock sales deal | 04/26/19 |
| No summary available. | |
| First exec indicted over role in opioid ... | 04/23/19 |
| No summary available. | |
| Titan Pharma files for $50M mixed shelf;... | 04/05/19 |
| No summary available. | |
| Titan Pharmaceuticals beats on revenue | 04/01/19 |
| No summary available. | |
| FDA's Gottlieb proposes higher standard ... | 03/28/19 |
| No summary available. | |
| Purdue Pharma settles opioid case in OK ... | 03/26/19 |
| No summary available. | |
| Canada to institute tighter restrictions... | 03/11/19 |
| No summary available. | |
| Painkiller stocks in the red on possible... | 03/04/19 |
| No summary available. | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 66.00 % | Follow |
| Burdeshaw Investing | Matthew Burdeshaw | 55.00 % | Subscribe |
| Tech and Bio Swing Trades | Matthew Burdeshaw | 46.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
